DRAX EXAMETAZIME
LIVE

Serial Number

87406433

Owner

Jubilant DraxImage Inc.

Attorney

Lisa M. Melanson

Filing Date

Apr 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

DRAX EXAMETAZIME Trademark

Serial Number: 87406433 • Registration: 6088036

DRAX EXAMETAZIME is a trademark filed by Jubilant DraxImage Inc. on April 11, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Jubilant DraxImage Inc.

16751 Trans-Canada Highway
Kirkland, QC H9H4J4 , CA

Entity Type: 03

Trademark Details

Filing Date

April 11, 2017

Registration Date

June 30, 2020

Published for Opposition

April 14, 2020

Goods & Services

Kit for the preparation of technetium Tc-99m exametazime injection for medical use comprising non-radioactive reagents

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 26, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 26, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 26, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 27, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 30, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 30, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 25, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 8, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 5, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 5, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 17, 2020 GNFN
FINAL REFUSAL E-MAILED
Jan 17, 2020 GNFR
FINAL REFUSAL WRITTEN
Jan 17, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 15, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 2, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 2, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 2, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 15, 2019 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 13, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 13, 2019 GNSL
SUSPENSION LETTER WRITTEN
Feb 13, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2019 CRFA
ASSIGNED TO LIE
Feb 11, 2019 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 4, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 15, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 15, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 15, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 14, 2018 RCCK
ASSIGNED TO LIE
Aug 6, 2018 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 17, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 17, 2018 GNSL
SUSPENSION LETTER WRITTEN
Jan 17, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 8, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jul 8, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jul 8, 2017 CNRT
ASSIGNED TO EXAMINER
Jul 5, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 18, 2017 NWOS
NEW APPLICATION ENTERED
Apr 14, 2017 NWAP